Junxin X. Wu

Fuma Road 420
Fuzhou, 350014, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Correction: Risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer using a DeepSurv-based survival model.

Correction: Risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer using a DeepSurv-based survival model.

Journal: Frontiers in oncology
Published: June 06, 2026

Circularly Polarized SE-SERDS of Circulating cfDNA for Pretreatment Prediction of Nasopharyngeal Carcinoma Recurrence.

Circularly Polarized SE-SERDS of Circulating cfDNA for Pretreatment Prediction of Nasopharyngeal Carcinoma Recurrence.

Journal: ACS sensors
Published: May 15, 2026

Upper Versus Middle-Neck Involvement in TNM-9 Stage IB Nasopharyngeal Carcinoma: Implications for De-Escalation and Intensification Strategies.

Upper Versus Middle-Neck Involvement in TNM-9 Stage IB Nasopharyngeal Carcinoma: Implications for De-Escalation and Intensification Strategies.

Journal: Cancer medicine
Published: May 13, 2026

EFHD2 drives lactate-mediated DNA damage repair and immunosuppression via HMGB1 and HIF-1α to confer radioresistance in colorectal cancer.

EFHD2 drives lactate-mediated DNA damage repair and immunosuppression via HMGB1 and HIF-1α to confer radioresistance in colorectal cancer.

Journal: Cell death & disease
Published: April 08, 2026

Leveraging data-driven risk-adapted surveillance strategies after disease progression in locally advanced rectal cancer.

Leveraging data-driven risk-adapted surveillance strategies after disease progression in locally advanced rectal cancer.

Journal: BMC cancer
Published: March 16, 2026

Risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer using a DeepSurv-based survival model.

Risk stratification for adjuvant radiotherapy in pathologic T3N0 rectal cancer using a DeepSurv-based survival model.

Journal: Frontiers in oncology
Published: March 12, 2026

Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Journal: Journal of applied clinical medical physics
Published: October 09, 2025

Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.

Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.

Journal: Cancer communications (London, England)
Published: April 24, 2025

Safety and efficacy analysis of neoadjuvant radiotherapy combined with concurrent paclitaxel plus nedaplatin versus other platinum-based chemotherapy for thoracic segmental esophageal squamous cell carcinoma.

Safety and efficacy analysis of neoadjuvant radiotherapy combined with concurrent paclitaxel plus nedaplatin versus other platinum-based chemotherapy for thoracic segmental esophageal squamous cell carcinoma.

Journal: Frontiers in oncology
Published: February 24, 2025

Tumor size in the management of preoperative radiotherapy for locally advanced rectal cancer.

Tumor size in the management of preoperative radiotherapy for locally advanced rectal cancer.

Journal: Discover oncology
Published: December 22, 2024

G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learning.

G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learning.

Journal: Journal of translational medicine
Published: November 06, 2024

Prognostic value of ubiquitination-related differentially expressed genes in esophageal squamous cell carcinoma: a comprehensive analysis and future directions.

Prognostic value of ubiquitination-related differentially expressed genes in esophageal squamous cell carcinoma: a comprehensive analysis and future directions.

Journal: Journal of thoracic disease
Published: October 29, 2024
Showing 1-12 of 70

Last Updated: 09/26/2026